External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy

JAMA Netw Open. 2022;5(1):e2144170. doi:10.1001/jamanetworkopen.2021.44170 – January 19, 2022

How does a previously prospectively derived clinical score for patients with neuroendocrine tumors under consideration for peptide receptor Radionuclide therapy perform prognostically in an external validation cohort?

Read full article>>